Acropolis Investment Management’s Medtronic MDT Stock Holding History

Acropolis Investment Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-817	Closed	-$102K	–	237
2021 Q3	$102K	Hold	817	–	–	0.01%	224
2021 Q2	$101K	Buy	+817	New	+$103K	0.01%	223
2021 Q1	–	Sell	-984	Closed	-$115K	–	220
2020 Q4	$115K	Buy	984 +7	+0.7%	+$771	0.01%	203
2020 Q3	$102K	Buy	+977	New	+$98.1K	0.01%	200
2020 Q1	–	Sell	-975	Closed	-$111K	–	189
2019 Q4	$111K	Hold	975	–	–	0.02%	165
2019 Q3	$106K	Buy	+975	New	+$102K	0.02%	162
2019 Q2	–	Sell	-2,238	Closed	-$204K	–	145
2019 Q1	$204K	Buy	+2,238	New	+$200K	0.03%	117
2018 Q4	–	Sell	-1,152	Closed	-$113K	–	147
2018 Q3	$113K	Buy	+1,152	New	+$107K	0.02%	136
2018 Q2	–	Sell	-4,075	Closed	-$327K	–	144
2018 Q1	$327K	Buy	4,075 +200	+5%	+$16.5K	0.05%	104
2017 Q4	$313K	Hold	3,875	–	–	0.05%	105
2017 Q3	$301K	Hold	3,875	–	–	0.05%	103
2017 Q2	$344K	Sell	3,875 -500	-11%	-$42.2K	0.06%	102
2017 Q1	$352K	Hold	4,375	–	–	0.06%	98
2016 Q4	$312K	Hold	4,375	–	–	0.06%	106
2016 Q3	$378K	Hold	4,375	–	–	0.07%	92
2016 Q2	$380K	Hold	4,375	–	–	0.07%	95
2016 Q1	$328K	Hold	4,375	–	–	0.06%	101
2015 Q4	$337K	Hold	4,375	–	–	0.07%	98
2015 Q3	$293K	Hold	4,375	–	–	0.06%	97
2015 Q2	$324K	Sell	4,375 -595	-12%	-$45.5K	0.06%	94
2015 Q1	$388K	Buy	4,970 +3,500	+238%	+$265K	0.07%	96
2014 Q4	$106K	Buy	+1,470	New	+$102K	0.02%	142
2014 Q1	–	Sell	-5,728	Closed	-$329K	–	134
2013 Q4	$329K	Sell	5,728 -276	-5%	-$15.7K	0.07%	92
2013 Q3	$320K	Buy	6,004 +190	+3%	+$10.2K	0.07%	94
2013 Q2	$299K	Buy	+5,814	New	+$287K	0.06%	88

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Acropolis Investment Management's MDT Position: Q4 2021 in Review

Acropolis Investment Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 817 shares — an estimated $102K sold.

Acropolis Investment Management first reported a position in MDT in Q2 2013 and held it in 25 quarters. The position peaked at $388K in Q1 2015. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

Acropolis Investment Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
Acropolis Investment Management sold 817 Medtronic shares in Q4 2021, an estimated $102K.
Acropolis Investment Management first reported a position in Medtronic in Q2 2013 and held it in 25 quarters.
Acropolis Investment Management's Medtronic position peaked at $388K in Q1 2015.
2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Acropolis Investment Management's 13F filing for Q4 2021, filed 14 Jan 2022.